Pfizer Secures Starna’s In‑Vivo CAR‑T Platform for Autoimmune Breakthroughs
Pfizer secures Starna’s pre‑clinical in‑vivo CAR‑T platform for autoimmune diseases, boosting its pipeline and positioning it for high‑growth, patent‑cliff‑resilient biotech opportunities.
5 minutes to read









